Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000539783 | SCV000659176 | benign | Dilated cardiomyopathy 1KK | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000617254 | SCV000740098 | likely benign | Cardiovascular phenotype | 2016-12-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome Diagnostics Laboratory, |
RCV000539783 | SCV000743681 | likely benign | Dilated cardiomyopathy 1KK | 2017-04-11 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000857771 | SCV001893597 | likely benign | not provided | 2020-01-09 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002491112 | SCV002794626 | likely benign | Dilated cardiomyopathy 1KK; MYPN-related myopathy | 2021-10-01 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV000539783 | SCV000732943 | likely benign | Dilated cardiomyopathy 1KK | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV001700162 | SCV001922903 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000857771 | SCV001956794 | likely benign | not provided | no assertion criteria provided | clinical testing |